NZMP SureStart™ LactoB HN001™
Lacticaseibacillus rhamnosus HN001*
An extensively studied probiotic, SureStart™ LactoB HN001™ supports immunity and health for mothers, infants and young children.
Supports Infant Immunity
Clinically tested to protect against eczema and reduce the risk of respiratory allergies such as hay fever and rhinitis.
Supports Maternal Wellbeing
May help to reduce the risk of gestational diabetes and postnatal depression.
High Shelf Life
Proprietary manufacturing techniques create more robust probiotics for NZMP powder applications.
China Approved Strain
One of only a few approved probiotics for use in foods for infants and young children in China.
Globally, 10% of pregnant women and 13% of women post-birth experience a mental health problem.5 In China, 6-28% of women suffer from depression during pregnancy, while 10-28% suffer postnatal depression5.
NZ Clinical Study: A study with 423 pregnant women taking SureStart™ LactoB HN001™ from the second trimester until 6 months following birth demonstrated:
- Reduced prevalence of Gestational Diabetes Mellitus (GDM) during pregnancy, and
- Significantly reduced symptoms of postnatal depression and anxiety.
We would love to collaborate! Fill in the contact form by clicking below and an NZMP expert will be in touch.
NZMP BifidoB HN019™ Probiotic
An extensively researched probiotic strain to help appeal to a broad range of consumers, by addressing key health concerns.
Our complete SureStart™ range
Explore our broad range of high performing SureStart™ ingredients and solutions, developed through our profound expertise in milk components for paediatric applications.
-  Tang et.al 2018, The Epidemiology of Food Allergy in The Global Context.
-  Gao et.al Prevalence of GDM in mainland China: A systematic review and meta-analysis, 2019.
-  International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017.
-  Behboudi-Gandevani et.al, The impact of diagnostic criteria for GDM on its prevalence: as systematic review and meta-analysis, 2019.
-  The Effect of Maternal Depression on Infant Attachment: A Systematic Review Int. J. Environ. Res. Public Health 2020, 17, 2675; doi:10.3390/ijerph17082675.
This information is designed to give a brief overview of the nature and characteristics of our products as at the date of preparation. It does not constitute representations or warranties as to such characteristics, the functionality or potential applications of our products. You must assure yourself of these matters having regard to our detailed product specifications, your specific circumstances and market requirements.
* In April 2020 the Lactobacillus genus was reclassified, resulting in a name change of our probiotic from Lactobacillus rhamnosus HN001 to Lacticaseibacillus rhamnosus HN001. There is no change to the abbreviated scientific notation L.rhamnosus HN001. Additional information can be found here